Aβ Dynamics in LLMD

NCT05004987 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease
Major Depressive Disorder

Interventions

DRUG: Escitalopram Oxalate
DRUG: Placebo

Sponsor

NYU Langone Health

Collaborators

[object Object]